BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 6, 2006
View Archived Issues
VaxGen Shares Nosedive On Anthrax Vaccine Stall
The latest snag for VaxGen's anthrax vaccine sent shares down by more than half after the company said the FDA put rPA102 on clinical hold, delaying the second Phase II trial. (BioWorld Today)
Read More
Adventrx Adding $40M For Cancer, Anti-Infective Work
Read More
Smell Of Dollars Burning On Breeze Of Pre-Election
Read More
Switch In Congress Could Start Drug Pricing Scrutiny
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More